First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
Recruiting · NCT06727981 · Registry updated 2024-12-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-Line and Neoadjuvant Immunotherapy for Gastric Cancer | Advanced Gastric Cancer; Locally Advanced Gastric Carcinoma | Recruiting | Not stated | 2024-12-11 | NCT06727981 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Hospital of Shandong University | 249 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Qilu Hospital of Shandong University | Jinan | China | 138 |